Biotech CEO on RNAI and Medicine of the Future
Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.